Aim. To find if testosterone undecanoat 1000 mg injection (NebidoR; Bayer-Schering) has a negative effect on prostate. Material&Method. 1. PSA (ng/ml) was registred retrospective (from files) and prospective analysis (onset 2010). 2. From over 175 patients to whom testosterone undecanoat 1000 mg, i.m. was administrated at 3 months, in the last 4 years, and to whom the prostatic volume was quantified (J.Sex. Med., 2011, 8, suppl 
Conclusions.
1. Testosterone undecanoat 1000 mg injectable i.m. at 3 months does not increase significantly PSA level after 4 years administrations. 2. PSA level post testosterone is in fact dependent on age, prostatic volume before treatment and the level before treatment. 
